- Home
- BHC
as 07-26-2024 4:00pm EST
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Upcoming Earnings Alert:
Get ready for potential market movements as Bausch Health Companies Inc. BHC prepares to release earnings report on 01 Aug 2024.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | QUEBEC |
| Market Cap: | 2.8B | IPO Year: | N/A |
| Target Price: | $10.50 | AVG Volume (30 days): | 6.3M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.96 - $11.46 | Next Earning Date: | 08-01-2024 |
| Revenue: | $8,966,000,000 | Revenue Growth: | 10.01% |
| Revenue Growth (this year): | 8.51% | Revenue Growth (next year): | 3.45% |
Stock Insider Trading Activity of Bausch Health Companies Inc. (BHC)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Carson Seana | BHC | EVP, General Counsel | Feb 29 '24 | Sell | $9.80 | 4,420 | $43,316.00 | 501,798 | SEC Form 4 |
| Carson Seana | BHC | EVP, General Counsel | Feb 29 '24 | Sell | $9.80 | 199 | $1,950.20 | 501,599 | SEC Form 4 |
| Carson Seana | BHC | EVP, General Counsel | Feb 29 '24 | Sell | $9.80 | 1,561 | $15,297.80 | 500,038 | SEC Form 4 |
| Carson Seana | BHC | EVP, General Counsel | Feb 29 '24 | Sell | $9.80 | 133 | $1,303.40 | 499,905 | SEC Form 4 |
| Carson Seana | BHC | EVP, General Counsel | Dec 1 '23 | Sell | $7.38 | 220 | $1,623.60 | 382,925 | SEC Form 4 |
Latest Bausch Health Companies Inc. News
BHC Breaking Stock News: Dive into BHC Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Bausch Health (BHC) Earnings Expected to Grow: Should You Buy?
MT Newswires
a day ago
Truist Adjusts Bausch Health Companies' PT to $7 From $8, Maintains Hold Rating
Investopedia
2 days ago
Bausch Health Stock Swings Wildly as it Addresses Report It's Considering Bankruptcy
MT Newswires
2 days ago
Sector Update: Health Care Stocks Rise Late Afternoon
MT Newswires
2 days ago
Sector Update: Health Care
MT Newswires
2 days ago
Bausch Health Says Not Considering Bankruptcy as it Responds to Stock Plunge
MT Newswires
2 days ago
Update: Bausch Health Denies Bankruptcy Rumors
MT Newswires
2 days ago
Bausch Health Denies Bankruptcy Rumors
Compare BHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BHC Bausch Health Companies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.